TrialFrontiers in endocrinology2025

Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial.

Maciej Kolodziej et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.